Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Walters

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
Blood|December 15, 2016
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantationEliane Gluckman, Barbara Cappelli, Francoise Bernaudin, et al.
Blood Advances|October 29, 2024
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell diseaseMark C Walters, Mary Eapen, Yiwen Liu, et al.
Transplantation and Cellular Therapy|February 12, 2023
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsChenyu Lin, Aurelie Schwarzbach, Jaime Sanz, et al.
NEJM Evidence|February 25, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseAdetola A Kassim, Mark C Walters, Mary Eapen, et al.
The New England Journal of Medicine|April 19, 2018
Gene Therapy in Patients with Transfusion-Dependent β-ThalassemiaAlexis A Thompson, Mark C Walters, Janet Kwiatkowski, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
Blood|December 15, 2016
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantationEliane Gluckman, Barbara Cappelli, Francoise Bernaudin, et al.
Blood Advances|October 29, 2024
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell diseaseMark C Walters, Mary Eapen, Yiwen Liu, et al.
Transplantation and Cellular Therapy|February 12, 2023
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsChenyu Lin, Aurelie Schwarzbach, Jaime Sanz, et al.
NEJM Evidence|February 25, 2025
Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseAdetola A Kassim, Mark C Walters, Mary Eapen, et al.
The New England Journal of Medicine|April 19, 2018
Gene Therapy in Patients with Transfusion-Dependent β-ThalassemiaAlexis A Thompson, Mark C Walters, Janet Kwiatkowski, et al.
Pageof 9